You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HER2-negative invasive tumor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Tumors Trial in Guangzhou (procedure, drug, biological)

Recruiting
  • Breast Neoplasms
  • Sentinel Lymph Node Biopsy (SLNB)
  • +7 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 2, 2023

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Active, not recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +22 more
  • Biopsy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022

Breast Tumors Trial in Guangzhou (procedure, drug, biological)

Recruiting
  • Breast Neoplasms
  • Sentinel Lymph Node Biopsy (SLNB)
  • +7 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jul 31, 2023

Breast Tumors Trial in Guangzhou (procedure, drug, biological)

Recruiting
  • Breast Neoplasms
  • Surgery for harvesting tumor-draining lymph nodes
  • +6 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 2, 2023

Breast Tumors Trial in Guangzhou (procedure, drug, biological)

Recruiting
  • Breast Neoplasms
  • Surgery for harvesting tumor-draining lymph nodes
  • +8 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jul 31, 2023

Breast Cancer Trial (Pyrotinib, Trastuzumab, Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Apr 22, 2023

Breast Cancer Invasive, Hormone-receptor-positive Breast Cancer, HER2 Low Breast Carcinoma Trial in Guangzhou (Pyrotinib,

Not yet recruiting
  • Breast Cancer Invasive
  • +3 more
  • Pyrotinib, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
  • Placebo, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Nov 17, 2023

Clinical Outcomes in HR+ and HER2-low/Negative Breast Cancer

Active, not recruiting
  • Hormone-receptor-positive Breast Cancer
  • +2 more
  • No drug
  • Cambridge, Massachusetts
    ConcertAI database
Sep 8, 2023

HER2-negative and Hormone-receptor Positive Metastatic Breast Cancer, HER2-negative Circulating Tumor Cells, Postmenopausal

Active, not recruiting
  • HER2-negative and Hormone-receptor Positive Metastatic Breast Cancer
  • +2 more
  • Ulm, Baden-Württemberg, Germany
    University Hospital Ulm -Department of Gynecology
Jul 27, 2022

Non-Muscle Invasive Bladder Cancer, HER2 Trial (RC48, Tislelizumab)

Not yet recruiting
  • Non-Muscle Invasive Bladder Cancer
  • HER2
  • (no location specified)
Jul 16, 2023

Invasive Breast Cancer Trial in Milwaukee (Cemiplimab, Paclitaxel, Carboplatin (not mandatory))

Recruiting
  • Invasive Breast Cancer
  • Milwaukee, Wisconsin
    Froedtert Hospital & Medical College of Wisconsin
Apr 1, 2022

Gut and Tumor Microbiome in Advanced ER-positive and

Not yet recruiting
  • Breast Cancer
  • Melanoma
  • Observation
  • (no location specified)
Nov 6, 2023

Potential Clinical Utilities of Circulating Tumor DNA in

Not yet recruiting
  • Gastric Cancer
  • Circulating Tumor DNA (ctDNA)
    • (no location specified)
    Aug 21, 2022

    Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

    Not yet recruiting
    • Anatomic Stage I Breast Cancer AJCC v8
    • +5 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Jul 14, 2022

    ER+ HER2- Advanced Breast Cancer Trial in Chuo-ku, Kashiwa, Koto-ku (AZD9833)

    Active, not recruiting
    • ER+ HER2- Advanced Breast Cancer
    • Chuo-ku, Japan
    • +2 more
    Jan 24, 2023

    HER2-negative Breast Cancer, Advanced Solid Tumor Trial in Singapore (ADG106, Doxorubicin, Cyclophosphamide)

    Recruiting
    • HER2-negative Breast Cancer
    • Advanced Solid Tumor
    • Singapore, Singapore
      National University Hospital
    Jun 9, 2022

    Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Houston (Radiation Therapy, Therapeutic

    Active, not recruiting
    • Estrogen Receptor Positive
    • +3 more
    • Radiation Therapy
    • Therapeutic Conventional Surgery
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 14, 2022

    Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Tumor Trial (Elacestrant, Triptorelin)

    Not yet recruiting
    • Breast Cancer
    • +3 more
    • (no location specified)
    Aug 4, 2023

    HER2-low in Unresectable and/or Metastatic Breast Cancer

    Not yet recruiting
    • Breast Neoplasms, Breast Cancer, Breast Carcinoma, Genes, HER-2, Genes, HER2
      • (no location specified)
      Nov 6, 2023

      HER2-low in Metastatic Breast Cancer Patients

      Not yet recruiting
      • HER2-negative
        • (no location specified)
        Nov 9, 2023

        Breast Tumors Trial in Saint Louis (Doxorubicin, Trastuzumab, Cyclophosphamide)

        Terminated
        Has Results
        • Breast Neoplasms
        • Saint Louis, Missouri
          Washington University School of Medicine
        Oct 31, 2022

        HER2-negative Early Breast Cancer Trial in Beijing (neoadjuvant chemo upon in vitro PTC drug sensitivity screening for triple

        Recruiting
        • HER2-negative Early Breast Cancer
        • neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for triple negative breast cancer
        • neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for luminal like breast cancer
        • Beijing, China
          Peking University People's Hospital
        Mar 27, 2022

        HER2-negative Breast Cancer Trial in Budapest (device, drug, procedure)

        Recruiting
        • HER2-negative Breast Cancer
        • Oncotherm EHY-2030
        • +4 more
        • Budapest, Hungary
          Division of Oncology, Department of Internal Medicine and Oncolo
        May 25, 2023

        Breast Adenocarcinoma, Invasive Breast Carcinoma, Resectable Breast Carcinoma Trial in Jacksonville (Biospecimen Collection,

        Recruiting
        • Breast Adenocarcinoma
        • +2 more
        • Jacksonville, Florida
          Mayo Clinic in Florida
        Jan 4, 2023

        Survival Rate of HER2-Low Breast Cancer Patients

        Completed
        • HER2 Low Breast Carcinoma
        • immunohistochemistry (IHC) and in situ hybridization (ISH) Test
        • (no location specified)
        Mar 2, 2023